Applications in cardiology as well as neurology are fueling growing numbers of PET procedures and equipment sales, according to a report from Bio-Tech Systems. PET procedure volume could reach 11 million annually by 2021, which might propel the radiopharmaceutical market to $5 billion by the same year. Overall, U.S. and international markets are projected to grow at 8% to 10% annually, reaching worldwide PET scanner sales of $1.4 billion by 2021, and growth forecasts will remain positive as physicians develop more confidence in using PET and as PET/MR systems continue to gain ground.

Related Summaries